PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS

被引：357
作者：
ERICE, A
CHOU, S
BIRON, KK
STANAT, SC
BALFOUR, HH
JORDAN, MC
机构：
[1] UNIV MINNESOTA,HLTH SCI CTR,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,HLTH SCI CTR,DEPT PEDIAT,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,HLTH SCI CTR,DEPT MED,MINNEAPOLIS,MN 55455
[4] UNIV MINNESOTA,HLTH SCI CTR,DEPT MICROBIOL,MINNEAPOLIS,MN 55455
[5] OREGON HLTH SCI UNIV,DIV INFECT DIS,PORTLAND,OR 97201
[6] BURROUGHS WELLCOME CO,DEPT VIROL,RES TRIANGLE PK,NC 27709
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1989年 / 320卷 / 05期
关键词：
D O I：
10.1056/NEJM198902023200505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：289 / 293
页数：5
相关论文
共 35 条
[1]   9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE FOR CYTOMEGALO-VIRUS INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
BACH, MC ;
BAGWELL, SP ;
KNAPP, NP ;
DAVIS, KM ;
HEDSTROM, PS .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) :381-382
[2]   A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J].
BIRON, KK ;
FYFE, JA ;
STANAT, SC ;
LESLIE, LK ;
SORRELL, JB ;
LAMBE, CU ;
COEN, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) :8769-8773
[3]   METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J].
BIRON, KK ;
STANAT, SC ;
SORRELL, JB ;
FYFE, JA ;
KELLER, PM ;
LAMBE, CU ;
NELSON, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) :2473-2477
[4]   9-(1,3-DIHYDROXY-2-PROPOXYMETHYL) GUANINE (GANCICLOVIR) IN THE TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL-DISEASE WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
CHACHOUA, A ;
DIETERICH, D ;
KRASINSKI, K ;
GREENE, J ;
LAUBENSTEIN, L ;
WERNZ, J ;
BUHLES, W ;
KORETZ, S .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) :133-137
[5]   ACQUISITION OF DONOR STRAINS OF CYTOMEGALOVIRUS BY RENAL-TRANSPLANT RECIPIENTS [J].
CHOU, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (22) :1418-1423
[6]   INVITRO SUSCEPTIBILITY OF CYTOMEGALOVIRUS ISOLATES FROM IMMUNOCOMPROMISED PATIENTS TO ACYCLOVIR AND GANCICLOVIR [J].
COLE, NL ;
BALFOUR, HH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 6 (03) :255-261
[7]   MULTIPLE INFECTIONS BY CYTOMEGALOVIRUS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME - DOCUMENTATION BY SOUTHERN BLOT HYBRIDIZATION [J].
DREW, WL ;
SWEET, ES ;
MINER, RC ;
MOCARSKI, ES .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (06) :952-953
[8]   GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS AND OTHER IMMUNOCOMPROMISED HOSTS [J].
ERICE, A ;
JORDAN, C ;
CHACE, BA ;
FLETCHER, C ;
CHINNOCK, BJ ;
BALFOUR, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (22) :3082-3087
[9]   TREATMENT OF CYTOMEGALO-VIRUS RETINITIS WITH 9-[2-HYDROXY-1-(HYDROXYMETHYL)ETHOXYMETHYL]GUANINE [J].
FELSENSTEIN, D ;
DAMICO, DJ ;
HIRSCH, MS ;
NEUMEYER, DA ;
CEDERBERG, DM ;
DEMIRANDA, P ;
SCHOOLEY, RT .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) :377-380
[10]   HUMAN PHARMACOKINETICS OF THE ANTIVIRAL DRUG DHPG [J].
FLETCHER, C ;
SAWCHUK, R ;
CHINNOCK, B ;
DEMIRANDA, P ;
BALFOUR, HH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) :281-286
1234